Stock CBPO CHINA BIOLOGIC PRODUCTS HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News China Biologic Products Holdings, Inc.

Equities

CBPO

KYG215151047

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Snapshot: The Resurgence Of Take-private Transactions In Asia
AQ
China Biologic Products Holdings, Inc.(NasdaqGS:CBPO) dropped from S&P Global BMI Index
CI
China Biologic Products Holdings, Inc.(NasdaqGM:CBPO) dropped from FTSE All-World Index
CI
China Biologic Products : Announces Completion of Going Private Transaction
PR
China Biologic Products Holdings, Inc.(NasdaqGS:CBPO) dropped from NASDAQ Biotechnology Index
CI
China Biologic Products Holdings, Inc.(NasdaqGM:) dropped from NASDAQ Composite Index
CI
Centurium Capital Management Ltd., CITIC Capital Partners Management Ltd., Parfield International Ltd., V-Sciences Investments Pte Ltd, Hillhouse Capital Management, Ltd. and Joseph Chow, Chairman and Chief Executive Officer of China Biologic Products Holdings, Inc. completed the acquisition of remaining 31.16% stake in China Biologic Products Holdings, Inc..
CI
China Biologic Products : CBPO 4Q20 Presentation Material
PU
China Biologic Products: Q4 Earnings Snapshot
AQ
China Biologic Products Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020
CI
China Biologic Products : Q4 Profit, Revenue Rise from Year Ago
MT
China Biologic Products : Reports Financial Results for the Fourth Quarter and Fiscal Year 2020
PR
China Biologic Products : Announces Shareholders' Approval of Merger Agreement
PR
China Biologic Products : Announces Extraordinary General Meeting of Shareholders
PR
China Biologic Products Holdings, Inc. Announces Resignation of Yue’e Zhang from the Board of Directors
CI
Joseph Chow, the Chairman of the Board of Directors and Chief Executive Officer of CBPO completed the acquisition of 9.72% stake in China Biologic Products Holdings, Inc. from PW Medtech Group Limited.
CI
Joseph Chow, the Chairman of the Board of Directors and Chief Executive Officer of CBPO completed the acquisition of 2% stake in China Biologic Products Holdings, Inc. from PW Medtech Group Limited.
CI
CITIC Capital Holdings Limited completed the acquisition of 2.4% stake in China Biologic Products Holdings, Inc. from PW Medtech Group Limited.
CI
Transcript : China Biologic Products Holdings, Inc., Q3 2020 Earnings Call, Nov 25, 2020
China Biologic Products : CBPO 3Q20 Presentation Material
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CBPO Stock
  4. News China Biologic Products Holdings, Inc.